Exploring the impact of dietary theobromine on endometriosis risk: Evidence from Mendelian randomization and NHANES data

Endometriosis is a chronic inflammatory estrogen-dependent inflammatory disorder. Theobromine has been implicated in diverse health benefits, including anti-inflammatory and vasodilatory properties. However, the precise association between theobromine and endometriosis remains largely undetermined. To address this gap, this study sought to explore the causal relationship between theobromine exposure and the risk of endometriosis by leveraging Mendelian randomization (MR) and data from the National Health and Nutrition Examination Survey (NHANES). This study included 244 participants from the NHANES (1999-2004). Multivariable logistic regression (adjusted for age, body mass index, smoking, alcohol intake, and energy intake) assessed associations between dietary theobromine intake and endometriosis diagnosis age. Two-sample MR (16,588 cases/1,11,583 controls) used 12 theobromine-associated single-nucleotide polymorphisms (P < 5 × 10⁻⁸) as instruments, with inverse variance weighted analysis. MR assumptions were verified via F-statistics (>10), heterogeneity (Cochran's Q P > .05), and pleiotropy (MR-Egger P > .05). In the observational study (NHANES), each 1 μg/d increment in dietary theobromine intake was associated with a 1.49-year delay in endometriosis diagnosis age (β = 1.49, 95% CI: 0.02-2.95, P = .048) after multivariable adjustment. In the MR analysis, the inverse variance weighted method showed a significant causal effect estimate of β = -0.1057 (95% CI: -0.2098 to -0.0016, P = .045) for the effect of theobromine on endometriosis risk. Sensitivity analyses confirmed robustness against pleiotropy and heterogeneity. This study suggests a potential causal relationship between dietary theobromine intake and a modestly reduced risk of endometriosis, providing preliminary insights into the potential protective effects of theobromine against the development of this condition. However, further investigations are necessary to validate these findings and to understand the underlying biological mechanisms.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2025-11-21
DOI
https://doi.org/10.1097/md.0000000000045989
Primary Topic
Endometriosis Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the impact of dietary theobromine on endometriosis risk: Evidence from Mendelian randomization and NHANES data

Yingqin Huang, Baoli Xie, Feng Liang, Dongmei Huang
Medicine
Endometriosis Research and Treatment
article

Exploring the impact of dietary theobromine on endometriosis risk: Evidence from Mendelian randomization and NHANES data

Yingqin Huang, Baoli Xie, Feng Liang, Dongmei Huang
article en

Abstract

Endometriosis is a chronic inflammatory estrogen-dependent inflammatory disorder. Theobromine has been implicated in diverse health benefits, including anti-inflammatory and vasodilatory properties. However, the precise association between theobromine and endometriosis remains largely undetermined. To address this gap, this study sought to explore the causal relationship between theobromine exposure and the risk of endometriosis by leveraging Mendelian randomization (MR) and data from the National Health and Nutrition Examination Survey (NHANES). This study included 244 participants from the NHANES (1999-2004). Multivariable logistic regression (adjusted for age, body mass index, smoking, alcohol intake, and energy intake) assessed associations between dietary theobromine intake and endometriosis diagnosis age. Two-sample MR (16,588 cases/1,11,583 controls) used 12 theobromine-associated single-nucleotide polymorphisms (P < 5 × 10⁻⁸) as instruments, with inverse variance weighted analysis. MR assumptions were verified via F-statistics (>10), heterogeneity (Cochran's Q P > .05), and pleiotropy (MR-Egger P > .05). In the observational study (NHANES), each 1 μg/d increment in dietary theobromine intake was associated with a 1.49-year delay in endometriosis diagnosis age (β = 1.49, 95% CI: 0.02-2.95, P = .048) after multivariable adjustment. In the MR analysis, the inverse variance weighted method showed a significant causal effect estimate of β = -0.1057 (95% CI: -0.2098 to -0.0016, P = .045) for the effect of theobromine on endometriosis risk. Sensitivity analyses confirmed robustness against pleiotropy and heterogeneity. This study suggests a potential causal relationship between dietary theobromine intake and a modestly reduced risk of endometriosis, providing preliminary insights into the potential protective effects of theobromine against the development of this condition. However, further investigations are necessary to validate these findings and to understand the underlying biological mechanisms.

MedicineVol. 104(47)
Guangxi Zhuang Autonomous Region Health and Family Planning (CN), The People's Hospital of Guangxi Zhuang Autonomous Region (CN), Guangxi Maternal and Child Health Hospital (CN), First People's Hospital of Nanning (CN)
Openalex Percentile: Top 53%
Endometriosis Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.